Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 10, 2022

SELL
$255.51 - $362.11 $455,574 - $645,642
-1,783 Closed
0 $0
Q4 2021

Feb 04, 2022

BUY
$351.38 - $448.68 $20,028 - $25,574
57 Added 3.3%
1,783 $672,000
Q3 2021

Nov 05, 2021

SELL
$372.64 - $458.3 $14,532 - $17,873
-39 Reduced 2.21%
1,726 $712,000
Q2 2021

Jul 27, 2021

SELL
$294.17 - $371.65 $85,309 - $107,778
-290 Reduced 14.11%
1,765 $653,000
Q1 2021

Apr 26, 2021

SELL
$249.67 - $299.48 $58,422 - $70,078
-234 Reduced 10.22%
2,055 $596,000
Q4 2020

Feb 05, 2021

SELL
$222.0 - $252.62 $25,308 - $28,798
-114 Reduced 4.74%
2,289 $572,000
Q3 2020

Oct 29, 2020

BUY
$175.56 - $226.45 $110,251 - $142,210
628 Added 35.38%
2,403 $544,000
Q2 2020

Jul 23, 2020

BUY
$118.84 - $189.72 $210,941 - $336,753
1,775 New
1,775 $309,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.48B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Corbett Road Capital Management, LLC Portfolio

Follow Corbett Road Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Corbett Road Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Corbett Road Capital Management, LLC with notifications on news.